Clark Wealth Partners’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.4K Buy
460
+4
+0.9% +$204 0.01% 180
2026
Q2
$24.1K Buy
456
+4
+0.9% +$212 0.01% 171
2026
Q1
$25.2K Buy
452
+3
+0.7% +$163 0.02% 156
2025
Q4
$22K Hold
449
– – 0.01% 164
2025
Q3
$22K Buy
449
+10
+2% +$391 0.01% 164
2025
Q2
$16.9K Buy
439
+5
+1% +$191 0.01% 167
2025
Q1
$16.8K Buy
434
+5
+1% +$183 0.01% 162
2024
Q4
$14.5K Buy
+429
New +$15.4K 0.01% 148

Other funds holding GSK

Clark Wealth Partners's GSK Position: Q3 2026 in Review

Clark Wealth Partners increased its GSK (GSK) stake by 0.88% in Q3 2026, buying an estimated $204 and bringing the position to 460 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #180.

Clark Wealth Partners first reported a position in GSK in Q4 2024 and has held it in 8 quarters since. The position peaked at $25.2K in Q1 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Clark Wealth Partners held 460 shares of GSK worth $22.4K as of Q3 2026.
  • Clark Wealth Partners bought 4 GSK shares in Q3 2026, an estimated $204.
  • GSK made up 0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #180 holding.
  • Clark Wealth Partners first reported a position in GSK in Q4 2024 and has held it in 8 quarters since.
  • Clark Wealth Partners's GSK position peaked at $25.2K in Q1 2026.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.